ZF BIOTOX and SBH Sciences Join forces to offer Cell in Well™ service to the US Biotech Industry

NATICK, Mass. - July 15, 2013 - PRLog -- (Natick, MA, USA and Santona, Cantabria, Spain) July, 15, 2013.

ZF Biotox and SBH Sciences announced today the signing of a strategic collaboration agreement for the promotion of Cell in Well™ proprietary service in the US. SBH Sciences and ZF Biotox, are both innovative pre-clinical Contract Research Organizations providing complementary services to the Biopharmaceutical and pharmaceutical industries. The agreement will enable expansion of services mainly toward cell-based assays including High Throughput Screening.

Dr. Raphael Nir, SBH President and CSO said: "We are excited to be working with ZF BIOTOX, leaders in the development of cryopreservation techniques. The utilization of Cell in Well™ will allow us to offer even more prompt and reproducible cell-based assays to our customers. Moreover, we are pleased to offer to the biotech industry in the US and Canada this innovative and promising technique at very reasonable cost and with very prompt delivery time”.  

Andoni Cruz, ZF BIOTOX CEO said: “We are very pleased to collaborate with SBH, a consolidated contract research company with a long track record providing a good service to the pharmaceutical industry. This strategic partnership will allow Cell in Well™to open the American market and many companies using cell-based assays will be able to benefit from the outsourcing of this cell culture innovative service.”

About ZF BIOTOX :

ZF BIOTOX S.L. is a Spanish R&D biotech founded in 2009 that stands in the forefront of the cryopreservation field. The company provides disruptive freezing technologies that aim to facilitate cell therapy solutions and to streamline High Throughput Screening campaigns. Cell in Well™ is a proprietary in vitro technology that provides frozen cells in microplates ready-to-use in cell-based assays, reducing the assay-to-assay variability as well as the cell culturing time and costs associated with cell handling.

About SBH Sciences:

SBH Sciences is an innovative pre-clinical contract research organization, located in Natick, Massachusetts. SBH Sciences has been chosen by over 100 biotechnology and pharmaceutical companies for their service needs since 1997. SBH Sciences unique cell based bioassays, ELISA assays, cytokines, glycosyltransferases, and monoclonal antibodies, are applied to facilitate the process of discovery and bio-pharmaceutical development and to assist its customers to reach their clinical development goals. SBH Sciences provides flexible, innovative and on-time services customized to the customer needs.